Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages.
Wada T, Senokuchi T, Shi Y, Furusho T, Morita Y, Sarie M, Hanatani S, Fukuda K, Ishii N, Matsumura T, Fujiwara Y, Komohara Y, Araki E, Kubota N.
Wada T, et al. Among authors: ishii n.
Atherosclerosis. 2024 Dec 12;401:119088. doi: 10.1016/j.atherosclerosis.2024.119088. Online ahead of print.
Atherosclerosis. 2024.
PMID: 39705906
Free article.